Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert H Mach

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
Synapse (New York, N.Y.)|February 23, 2010
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamenJinbin Xu, Babak Hassanzadeh, Wenhua Chu, et al.
Synapse (New York, N.Y.)|June 15, 2013
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineBrian C Nolan, Shinban Liu, Lindsey R Hammerslag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2024
Development of Pyridothiophene Compounds for PET Imaging of α-SynucleinAnna Pees, Junchao Tong, Saritha Birudaraju, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Bacterial infection imaging with [<sup>18</sup>F]fluoropropyl-trimethoprimMark A Sellmyer, Iljung Lee, Catherine Hou, et al.
Molecular Oncology|April 16, 2014
Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134Yassar M Hashim, Dirk Spitzer, Suwanna Vangveravong, et al.
Cancer Research Communications|January 13, 2025
Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early RecurrenceElizabeth S McDonald, Tien-Chi Pan, Dhruv K Pant, et al.
Journal of Medicinal Chemistry|April 11, 2022
Screening of σ<sub>2</sub> Receptor Ligands and <i>In Vivo</i> Evaluation of <sup>11</sup>C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ<sub>2</sub> Receptor Brain PET TracerHo Young Kim, Ji Youn Lee, Chia-Ju Hsieh, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerYassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal, et al.
Cell Death Discovery|February 1, 2019
TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell deathChenbo Zeng, Chi-Chang Weng, Mark E Schneider, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2017
Absorbed radiation dosimetry of the D<sub>3</sub>-specific PET radioligand [<sup>18</sup>F]FluorTriopride estimated using rodent and nonhuman primateRichard Laforest, Morvarid Karimi, Stephen M Moerlein, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
Synapse (New York, N.Y.)|February 23, 2010
[3H]4-(dimethylamino)-N-(4-(4-(2-methoxyphenyl)piperazin-1-yl) butyl)benzamide: a selective radioligand for dopamine D(3) receptors. II. Quantitative analysis of dopamine D(3) and D(2) receptor density ratio in the caudate-putamenJinbin Xu, Babak Hassanzadeh, Wenhua Chu, et al.
Synapse (New York, N.Y.)|June 15, 2013
Fos expression in response to dopamine D3-preferring phenylpiperazine drugs given with and without cocaineBrian C Nolan, Shinban Liu, Lindsey R Hammerslag, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|February 14, 2024
Development of Pyridothiophene Compounds for PET Imaging of α-SynucleinAnna Pees, Junchao Tong, Saritha Birudaraju, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 19, 2017
Bacterial infection imaging with [<sup>18</sup>F]fluoropropyl-trimethoprimMark A Sellmyer, Iljung Lee, Catherine Hou, et al.
Molecular Oncology|April 16, 2014
Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134Yassar M Hashim, Dirk Spitzer, Suwanna Vangveravong, et al.
Cancer Research Communications|January 13, 2025
Ternary Complex Components Responsible for Rapid LDL Internalization as Biomarkers for Breast Cancer Associated with Proliferation and Early RecurrenceElizabeth S McDonald, Tien-Chi Pan, Dhruv K Pant, et al.
Journal of Medicinal Chemistry|April 11, 2022
Screening of σ<sub>2</sub> Receptor Ligands and <i>In Vivo</i> Evaluation of <sup>11</sup>C-Labeled 6,7-Dimethoxy-2-[4-(4-methoxyphenyl)butan-2-yl]-1,2,3,4-tetrahydroisoquinoline for Potential Use as a σ<sub>2</sub> Receptor Brain PET TracerHo Young Kim, Ji Youn Lee, Chia-Ju Hsieh, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 19, 2017
The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancerYassar M Hashim, Suwanna Vangveravong, Narendra V Sankpal, et al.
Cell Death Discovery|February 1, 2019
TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell deathChenbo Zeng, Chi-Chang Weng, Mark E Schneider, et al.
American Journal of Nuclear Medicine and Molecular Imaging|January 13, 2017
Absorbed radiation dosimetry of the D<sub>3</sub>-specific PET radioligand [<sup>18</sup>F]FluorTriopride estimated using rodent and nonhuman primateRichard Laforest, Morvarid Karimi, Stephen M Moerlein, et al.
Pageof 29